EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib

Lisa Mayr, Sina Neyazi, Kallen Schwark, Maria Trissal, Alexander Beck, Jenna Labelle, Sebastian K Eder, Liesa Weiler-Wichtl, Joana G Marques, Carlos A O de Biagi-Junior, Costanza Lo Cascio, Owen Chapman und 48 weitere

Cancer Cell · 2025-04 · 43 (4) · 740-756.e8

DOI: 10.1016/j.ccell.2025.02.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025-04. Verfasst von Lisa Mayr und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA 02215, USA; D…. Hauptthemen laut MEDLINE: Glioma, Receptor, Platelet-Derived Growth Factor alpha, Brain Neoplasms, Pyrazoles. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaReceptor, Platelet-Derived Growth Factor alphaBrain NeoplasmsPyrazolesProtein Kinase InhibitorsAntineoplastic AgentsHumansAnimalsMiceChildFemaleAdolescentYoung AdultAdultMutationMaleXenograft Model Antitumor AssaysCell Line, TumorChild, PreschoolNeoplasm GradingBlood-Brain BarrierPyrrolesTriazinesAvapritinib

Stichwörter der Autor:innen

PDGFRA alterationPDGFRA amplificationPDGFRA inhibitorPDGFRA mutationavapritinibbrain penetrancediffuse midline gliomaglioblastomahigh-grade gliomatyrosine kinase inhibitor

Substanzen

Receptor, Platelet-Derived Growth Factor alphaPyrazolesProtein Kinase InhibitorsAntineoplastic AgentsPyrrolesTriazinesAvapritinib

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA 02215, USA; Department of Pediatrics and Adolescent Medicine, Comprehensive Center…
  • Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA 02215, USA.
  • Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
  • Center for Neuropathology and Prion Research, Ludwig Maximilians University Munich, Faculty of Medicine, Muenchen, 80539 Bayern, Germany.
  • Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA 02215, USA; St. Anna Children's Hospital, Department of Pediatrics and Adolescent M…
  • Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics and Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health
  • Pediatric Brain Tumor Foundation
  • Dana-Farber Cancer Institute
  • Ministerstvo Zdravotnictví Ceské Republiky
  • Sontag Foundation

Zitieren

APA

Mayr, L., Neyazi, S., Schwark, K., Trissal, M., Beck, A., Labelle, J., Eder, S. K., Weiler-Wichtl, L., Marques, J. G., de Biagi-Junior, C. A. O., Lo Cascio, C., Chapman, O., Sridhar, S., Kenkre, R., Dutta, A., Wang, S., Wang, J., Hack, O., Nascimento, A., …, & Beroukhim, R. (2025). Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer Cell, 43(4), 740-756.e8. https://doi.org/10.1016/j.ccell.2025.02.018

Vancouver

Mayr L, Neyazi S, Schwark K, Trissal M, Beck A, Labelle J, et al. Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer Cell. 2025;43(4):740-756.e8. doi:10.1016/j.ccell.2025.02.018

BibTeX
@article{Mayr2025,
  author = {Mayr, Lisa and Neyazi, Sina and Schwark, Kallen and Trissal, Maria and Beck, Alexander and Labelle, Jenna and Eder, Sebastian K and Weiler-Wichtl, Liesa and Marques, Joana G and de Biagi-Junior, Carlos A O and Lo Cascio, Costanza and Chapman, Owen and Sridhar, Sunita and Kenkre, Rishaan and Dutta, Aditi and Wang, Shanqing and Wang, Jessica and Hack, Olivia and Nascimento, Andrezza and Nguyen, Cuong M and Castellani, Sophia and Rozowsky, Jacob S and Groves, Andrew and Panditharatna, Eshini and Cruzeiro, Gustavo Alencastro Veiga and Haase, Rebecca D and Tabatabai, Kuscha and Madlener, Sibylle and Wadden, Jack and Adam, Tiffany and Kong, Seongbae and Miclea, Madeline and Patel, Tirth and Bruckner, Katharina and Senfter, Daniel and Lämmerer, Anna and Supko, Jeffrey and Guntner, Armin S and Palova, Hana and Neradil, Jakub and Stepien, Natalia and Lötsch-Gojo, Daniela and Berger, Walter and Leiss, Ulrike and Rosenmayr, Verena and Dorfer, Christian and Dieckmann, Karin and Peyrl, Andreas and Azizi, Amedeo A and Baumgartner, Alicia and Slaby, Ondrej and Pokorna, Petra and Clark, Louise M and Cameron, Amy and Nguyen, Quang-De and Wakimoto, Hiroaki and Dubois, Frank and Greenwald, Noah F and Bandopadhayay, Pratiti and Beroukhim, Rameen},
  title = {Effective targeting of PDGFRA-altered high-grade glioma with avapritinib},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {4},
  pages = {740--756.e8},
  doi = {10.1016/j.ccell.2025.02.018}
}
Kostenlos starten →